Daily Rhythm in Plasma N-acetyltryptamine. (June 2017)

• Record Type: Journal Article
• Authors: Backlund, Peter S.; Urbanski, Henryk F.; Doll, Mark A.; Hein, David W.; Bozinoski, Marjan; Mason, Christopher E.; Coon, Steven L.; Klein, David C.
• Is Part Of: Journal of biological rhythms. Volume 32:Number 3(2017:Jun.)
• Page Start: 195
• Page End: 211
• Publication Date: 2017-06
• Subjects: N-acetyltryptamine -- melatonin -- pineal -- retina -- human -- nonhuman primate -- daily rhythm -- transcriptome profiling; Biological rhythms -- Periodicals; Circadian rhythms -- Periodicals; 571.77
• DOI: 10.1177/0748730417700458
• Languages: English
• ISSNs: 0748-7304

Abstract

Normal physiology undergoes 24-h changes in function that include daily rhythms in circulating hormones, most notably melatonin and cortical steroids. This study focused on N-acetyltryptamine, a little-studied melatonin receptor mixed agonist-antagonist and the likely evolutionary precursor of melatonin. The central issue addressed was whether N-acetyltryptamine is physiologically present in the circulation. N-acetyltryptamine was detected by LC-MS/MS in daytime plasma of 3 different mammals in subnanomolar levels (mean ± SEM: rat, 0.29 ± 0.05 nM, n = 5; rhesus macaque, 0.54 ± 0.24 nM, n = 4; human, 0.03 ± 0.01 nM, n = 32). Analysis of 24-h blood collections from rhesus macaques revealed a nocturnal increase in plasma N-acetyltryptamine (p < 0.001), which varied from 2- to 15-fold over daytime levels among the 4 animals studied. Related RNA sequencing studies indicated that the transcript encoding the tryptamine acetylating enzyme arylalkylamine N-acetyltransferase (AANAT) is expressed at similar levels in the rhesus pineal gland and retina, thereby indicating that either tissue could contribute to circulating N-acetyltryptamine. The evidence that N-acetyltryptamine is a physiological component of mammalian blood and exhibits a daily rhythm, together with known effects as a melatonin receptor mixed agonist-antagonist, shifts the status of N-acetyltryptamine from pharmacological tool to candidate for a physiological role. This provides a new opportunity to extend our understanding of 24-h biology.